Health Care/Hospital
Innovative Aspiration Thrombectomy System by Expanse ICE Receives FDA Clearance for vessels of the peripheral arterial and venous systems
PLEASANTON, Calif., April 22, 2024 /PRNewswire/ -- Expanse ICE announced today the ICE Aspiration System has received 510(k) clearance from the U.S. Food and Drug Administration. This announcement introduces a new and exciting player in the peripheral thrombectomy market. The ICE System is spec...
Landmark New Publication: the Forgotten Biochemistry 101 of COVID-19
Legacy coronavirus biochemistry was overlooked that governs spike protein toxicity, key morbidities, risk factors and therapeutic responses SALT LAKE CITY, April 22, 2024 /PRNewswire/ -- TrialSite News features a paper published today in Viruses (Basel), authored by an international team of resea...
Yili Innovation Center Europe Kicks Off All-round Upgrades
WAGENINGEN, Netherlands, April 22, 2024 /PRNewswire/ -- On April 18th, local time inthe Netherlands, on the occasion of the 10th anniversary of the establishment of the Yili Innovation Center Europe (YICE), a ceremony themed "Connect Globally to Drive Innovation" was held at Wageningen University...
Leo Cancer Care Teams up With World-Leading Carbon Ion Centre
Partnership will see Upright Radiotherapy System Installed at World-Leading Cancer Centre MIDDLETON, Wis., April 22, 2024 /PRNewswire/ -- Leo Cancer Care's unique upright radiotherapy solution is set to be installed in one of the world's most advanced oncology centres to deliver proton and carbo...
Hyundai Bioscience announces its successful result from a preclinical study of a Niclosamide-based oral anticancer drug to treat triple-negative breast cancer
* Clinical trials of Niclosamide-based oral metabolic anticancer drug to commence for patients with difficult-to-treat cancers such as triple-negative breast cancer and pancreatic cancer * Niclosamide-based oral anticancer drug project to be carried out by the new subsidiary of Hyundai Biosci...
Earth Day 2024: Angel Yeast Continues to Tackle Plastic Pollution Challenges With Bio-based Material Solutions
SHANGHAI, April 22, 2024 /PRNewswire/ -- Themed "Planet vs. Plastics," the 55th
Earth Day serves as a deep reminder for everyone to play a role in
environmental protection.Angel Yeast
AGCO Agriculture Foundation Donates $450,000 AUD to Rural Aid Australia
DULUTH, Ga., April 22, 2024 /PRNewswire/ -- The AGCO Agriculture Foundation (the "Foundation"), a private foundation with the vision to prevent and relieve hunger through sustainable agriculture development, announced a$450,000 AUD grant to Rural Aid to support farmers' mental health and wellbein...
GT20029 China Phase II Trial For AGA Reached Primary Endpoint
SUZHOU, China, April 21, 2024 /PRNewswire/ -- Kintor Pharmaceutical Limited ("Kintor Pharma", HKEX: 9939), a clinical-stage biotechnology company developing innovative small molecules and biological therapeutics, announced thatthe China phase II clinical trial (the "Phase II Clinical Trial") of i...
Juniper Biologics Named "Pharmaceutical Company of the Year" at Corporate LiveWire Global Awards
SINGAPORE, April 18, 2024 /PRNewswire/ -- Juniper Biologics
Juniper Biologics Named "Pharmaceutical Company of the Year" at Corporate LiveWire Global Awards
SINGAPORE, April 22, 2024 /PRNewswire/ -- Juniper Biologics
BGI Genomics Leads Innovation with Inaugural Clinical Lab in Uruguay
Cutting-edge facility to serve as a beacon for preventive medicine in Latin America MONTEVIDEO, Uruguay, April 22, 2024 /PRNewswire/ -- BGI Genomics, a global leader in integrated precision medicine solutions, has established a new clinical laboratory atUruguay's Parque de las Ciencias free trad...
ASTRI's Wins 23 Awards Geneva Inventions Expo
Gemstones Identification Technology Earns Gold Medal with Congratulations of Jury HONG KONG, April 20, 2024 /PRNewswire/ -- The Hong Kong Applied Science and Technology Research Institute (ASTRI) has won 23 accolades at the 49th International Exhibition of Inventions Geneva, including 1 "Gold Me...
CONCEPT MEDICAL ANNOUNCES ENROLLMENT OF FIRST PATIENT IN "MAGICAL-ISR" IDE STUDY IN THE US
TAMPA, Fla., April 20, 2024 /PRNewswire/ -- Concept Medical
Inaugural 'Korea Medical Innovation Research Forum' regular seminar, a success
* To be registered as an official research organization by the National Assembly Secretariat... Expected to become Korea's leading medical think tank * Planning to initiate global multinational clinical projects in digital therapeutics * Establishing a future medical system centered aroun...
Concord Medical Files 2023 Annual Report on Form 20-F
BEIJING, April 19, 2024 /PRNewswire/ -- Concord Medical Services Holdings Limited ("Concord Medical" or the "Company") (NYSE: CCM), a healthcare provider specialized in cancer treatment, research, education and prevention inChina, today announced that it filed its annual report on Form 20-F for t...
MGI Tech's DNBSEQ-T20x2* Gene Sequencer Named 2024 Edison Award™ Gold Winner
FORT MYERS, Fla., April 19, 2024 /PRNewswire/ -- MGI Tech
YS Biopharma Announces Unaudited Financial Results for the First Nine Months of Fiscal Year 2024
GAITHERSBURG, Md., April 19, 2024 /PRNewswire/ -- YS Biopharma Co., Ltd. (NASDAQ: YS) ("YS Biopharma" or the "Company"), a global biopharmaceutical company dedicated to discovering, developing, manufacturing, and delivering new generations of vaccines and therapeutic biologics for infectious dise...
GenFleet Therapeutics Announces FDA's Clinical Trial Approval for GFH925 (KRAS G12C Inhibitor) Monotherapy in Phase III Registrational Study Treating Metastatic Colorectal Cancer
SHANGHAI, April 19, 2024 /PRNewswire/ -- GenFleet Therapeutics, a clinical-stage biotechnology company focusing on cutting-edge therapies in oncology and immunology, announced US Food and Drug Administration (FDA) has granted the clinical trial approval for GFH925 (KRAS G12C inhibitor) in a mult...
Global clinical development on Dengue antiviral candidate will start, Hyundai Bioscience strives to win emergency use authorization
SEOUL, South Korea, April 19, 2024 /PRNewswire/ -- South Korea's biotechnology
company Hyundai Bioscience (CEO Oh Sang-gi,www.hyundaibioscience.com
Global clinical development on Dengue antiviral candidate will start, Hyundai Bioscience strives to win emergency use authorization
SEOUL, South Korea, April 18, 2024 /PRNewswire/ -- South Korea's biotechnology
company Hyundai Bioscience (CEO Oh Sang-gi,www.hyundaibioscience.com
Week's Top Stories
Most Reposted
Earth Day 2024: Angel Yeast Continues to Tackle Plastic Pollution Challenges With Bio-based Material Solutions
[Picked up by 290 media titles]
2024-04-22 16:00Trina Solar and PetroGreen Partner to Accelerate Philippine Solar Adoption with 117MW Supply Agreement
[Picked up by 289 media titles]
2024-04-22 06:00With unique features, Hainan TV opened "The World's Specialty" pavilion at the Expo!
[Picked up by 287 media titles]
2024-04-18 21:26China's Yiwu Establishes Welcoming Committee to Attract International Buyers
[Picked up by 286 media titles]
2024-04-19 13:25Animated Life in Yunnan
[Picked up by 281 media titles]
2024-04-18 14:00